Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.

Abstract

We conclude that FAMP has major activity in follicular lymphoma. Fundamental research is needed to understand this differential efficacy in low-grade lymphoma yet lack of efficacy in intermediate- and high-grade lymphoma. Clinical investigations should be done using FAMP in varying dose schedules and in combination regimens.